Asthma Clinical Trials in Massachusetts

24 recruiting studies across 1 city

Browse by City

All Trials in Massachusetts

Phase

Trial	Phase	Sponsor	Dist.
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)	—	Duke University	<1 mi
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma	Phase 3	AstraZeneca	<1 mi
A Study of CDX-622 in Participants With Mild to Moderate Asthma	Phase 1	Celldex Therapeutics	<1 mi
Phenotyping Asthma for Bronchial Thermoplasty	—	Massachusetts General Hospital	<1 mi
A Phase II Study to Investigate Lung Function With 2 Different Doses of Inhaled Glycopyrronium Taken With BFF Compared to BFF in Participants of 4 to Less Than 12 Years of Age With Asthma	Phase 2	AstraZeneca	<1 mi
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma	Phase 2	Eli Lilly and Company	<1 mi
Comparative-effectiveness of a Healthy Lifestyle and Asthma Management Program, In-person vs. ONline	N/A	Massachusetts General Hospital	<1 mi
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma	Phase 3	Teva Branded Pharmaceutical Products R&D LLC	<1 mi
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation	Phase 1	Benjamin Medoff	<1 mi
Registry of Asthma Characterization and Recruitment 3 (RACR3)	—	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma	Phase 1	Amgen	<1 mi
Protocol CAUSE-03 / CHEETAH	—	National Institute of Allergy and Infectious Diseases (NIAID)	<1 mi
A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)	Phase 3	AstraZeneca	<1 mi
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma	Phase 3	AstraZeneca	<1 mi
Home Hospital for Suddenly Ill Adults	N/A	Brigham and Women's Hospital	<1 mi
Clinical Utility of Portable Dynamic Chest X Ray (DDR) in the ICU	N/A	Brigham and Women's Hospital	<1 mi
Telehealth and Onsite Maintenance Exercise in Chronic Lung Disease	N/A	MGH Institute of Health Professions	1 mi
Tissue Repository Providing Annotated Biospecimens for Approved Investigator-directed Biomedical Research Initiatives	—	Sanguine Biosciences	9 mi
Individualizing Treatment for Asthma in Primary Care (Full Study)	Phase 4	DARTNet Institute	39 mi
Asthma Link Effectiveness Trial	N/A	University of Massachusetts, Worcester	39 mi
Social Needs Screening and Chronic Diseases Study (WE CARE)	N/A	University of Massachusetts, Worcester	39 mi
Impact of Sleep Duration on Immune Balance in Urban Children With Asthma	N/A	Rhode Island Hospital	41 mi
The Puerto Rico Asthma Integrated Response Program ("PR-AIR")	N/A	Rhode Island Hospital	41 mi
Randomised Clinical Trial to Investigate Efficacy and Safety of Benralizumab 30 mg SC as an add-on Therapy in Uncontrolled Eosinophilic Asthma Patients Treated With Medium-dose ICS-LABA Compared to Conventional Escalation to High-dose ICS-LABA Treatment	Phase 3	AstraZeneca	49 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.